News25/Ratings9
News · 26 weeks47-25%
2025-10-262026-04-19
Mix1290d
- SEC Filings4(33%)
- Other3(25%)
- Leadership2(17%)
- Analyst1(8%)
- Insider1(8%)
- Offering1(8%)
Latest news
25 items- PRLumexa Imaging Appoints Kyle Lynch as Chief Growth OfficerRALEIGH, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company's enterprise growth strategy, with responsibility for expanding Lumexa Imaging's platform through joint ventures, acquisitions, and de novo development. In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and maximizing return on invested capita
- SECLumexa Imaging Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)
- SECSEC Form 10-K filed by Lumexa Imaging Holdings Inc.10-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)
- SECLumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)
- PRLumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 GuidanceRALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced certain financial results for the fourth quarter ended December 31, 2025, and reiterated full year 2026 guidance. The financial results included in this release pertaining to the fourth quarter and full year 2025 are preliminary, unaudited, and subject to final review and adjustment. "The fourth quarter of 2025 marked a strong close to an important year for Lumexa Imaging, with continued momentum across the business," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "Strong Adjusted EBITDA growth was driven by a
- PRMiddleby Appoints Glenn Eisenberg To Board of DirectorsThe Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,
- SECLumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)
- INSIDERPrincipal Accounting Officer Walker James Edward Jr. was granted 12,414 shares, increasing direct ownership by 252% to 17,346 units (SEC Form 4)4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)
- PRLumexa Imaging Announces Participation in Upcoming Investor ConferencesRALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences: Raymond James Institutional Investors Conference, being held in Orlando, Florida, including a presentation at 3:25pm EST on Monday, March 2, 2026.Leerink Partners Global Healthcare Conference, being held in Miami, Florida, including a fireside chat at 8:40am EST on Monday, Marc
- SECSEC Form SCHEDULE 13G filed by Lumexa Imaging Holdings Inc.SCHEDULE 13G - Lumexa Imaging Holdings, Inc. (0002071288) (Subject)
- ANALYSTLumexa Imaging Holdings upgraded by Raymond James with a new price targetRaymond James upgraded Lumexa Imaging Holdings from Outperform to Strong Buy and set a new price target of $23.00
- PRLumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered CareChair of Lumexa Imaging's Center for Quality will serve as the Radiological Society of North America's board liaison for government relations RALEIGH, N.C., Jan. 28, 2026 /PRNewswire/ -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, is proud to recognize Jennifer L. Kemp, MD, Chair of Lumexa Imaging's Center for Quality, has been elected to the Board of Directors of the Radiological Society of North America (RSNA). "Dr. Kemp's election to the RSNA Board reflects the depth of clinical leadership within our organization and t
- INSIDERChief Financial Officer Martin James Anthony was granted 54,054 shares (SEC Form 4)4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)
- INSIDERSEC Form 3 filed by new insider Martin James Anthony3 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)
- SECSEC Form 8-K filed by Lumexa Imaging Holdings Inc.8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)
- PRLumexa Imaging Achieves Record De Novo Expansion in 2025Company opens nine new outpatient imaging centers, expanding access to high-quality, cost-effective care RALEIGH, N.C., Jan. 8, 2026 /PRNewswire/ -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, set a company record by opening nine de novo centers in 2025. The two newest centers, located in Anderson, South Carolina and Cotswold, North Carolina, opened in December. With these new locations Lumexa Imaging now operates more than 185 centers across 13 states. The prior 2025 openings took place across New York, South Carolina and Texas.
- PRLumexa Imaging Announces Participation in Upcoming Investor ConferenceRALEIGH, N.C., Jan. 5, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the 44th Annual J.P. Morgan Healthcare Conference, being held in San Francisco, California, including a presentation at 7:30am PST on Monday, January 12, 2026. A webcast link and related presentation materials will be available online at https://ir.lumexaimaging.com. ABOUT LUMEXA IMAGING Lumexa Imaging is a nationwide pr
- ANALYSTAnalyst initiated coverage on Lumexa Imaging Holdings with a new price targetAnalyst initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00
- ANALYSTJefferies initiated coverage on Lumexa Imaging Holdings with a new price targetJefferies initiated coverage of Lumexa Imaging Holdings with a rating of Buy and set a new price target of $23.00
- ANALYSTWells Fargo initiated coverage on Lumexa Imaging Holdings with a new price targetWells Fargo initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $22.00
- ANALYSTWilliam Blair initiated coverage on Lumexa Imaging HoldingsWilliam Blair initiated coverage of Lumexa Imaging Holdings with a rating of Outperform
- ANALYSTRaymond James initiated coverage on Lumexa Imaging Holdings with a new price targetRaymond James initiated coverage of Lumexa Imaging Holdings with a rating of Outperform and set a new price target of $23.00
- ANALYSTLeerink Partners initiated coverage on Lumexa Imaging Holdings with a new price targetLeerink Partners initiated coverage of Lumexa Imaging Holdings with a rating of Outperform and set a new price target of $23.00
- ANALYSTDeutsche Bank initiated coverage on Lumexa Imaging Holdings with a new price targetDeutsche Bank initiated coverage of Lumexa Imaging Holdings with a rating of Buy and set a new price target of $22.00
- ANALYSTBarclays initiated coverage on Lumexa Imaging Holdings with a new price targetBarclays initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00